• Explore /
  • Poster
  • / A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with <i>candida </i>skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.

A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.

Abstract Poster

Authors

null

Mayumi Nakagawa

University of Arkansas for Medical Sciences, Little Rock, AR

Mayumi Nakagawa , Shawna L. Stratton , Rebecca Myrick , Rita Vaughn , Lisa M. Donnalley , Hannah Coleman , Maria Mercado , Andrea Moerman-Herzog , Horace J Spencer , Wilbur C. Hitt , Gordon Low , Nirvana Manning , Samantha McKelvey , Dora Smith , Michael Smith , Amy Phillips , C. Matthew Quick , Susanne K. Jeffus , Laura Fulper Hutchins , William Greenfield

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Immunotherapy and Biologic Therapy

Clinical Trial Registration Number

NCT00569231

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3032)

DOI

10.1200/jco.2015.33.15_suppl.3032

Abstract #

3032

Poster Bd #

358

Abstract Disclosures

Similar Posters

First Author: Marije Slingerland

First Author: Rahul Ravilla

First Author: Matthew P Morrow

First Author: Zev A. Wainberg